Stopping of adalimumab in juvenile idiopathic arthritis-associated uveitis (ADJUST): a multicentre, double-masked, randomised controlled trial Hosted By: Mile Brujic, OD, FAAO Topical Editor: Stephanie Stephanie Martich, OD, FAAO Topical Expert: Valerie Baca, OD, FAAO Publication: https://pubmed.ncbi.nlm.nih.gov/39863370/